Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| GIMEMA CLL0809 Study (BendOfa) (NCT01244451) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2010-12-01 |
Track Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or automatically
Every clearance here is in the API, with alerts when new ones post.